6,678 trials
Rheumatoid Arthritis
Primary: Change From Baseline in Clinical Disease Activity Index (CDAI) Score — 0; 0; 0; 0 Participants
Neovascular Macular Degeneration
Primary: Mean Change in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment of Diabetic Retinopathy Study (ETDRS) Letter Scores From Baseline to Week 52 - Last…
Schizophrenia · Type 2 Diabetes Mellitus
Primary: Change in Total Body Fat (kg). — 0.15; -1.77; -1.27 change in kilograms — p=0.03
Colorectal Neoplasms
Primary: Number of Participants With Detected Proximal Diminutive (<10 mm) Adenoma Detection Rate — 86; 89; 83; 38 participants
Acellular Pertussis · Tetanus · Diphtheria
Primary: Number of Subjects With Anti-diphtheria (Anti-DT) and Anti-tetanus Toxoid (Anti-TT) Antibody Concentrations Equal to or Above (≥) 0.1 International Units Per Milliliter…
Allergic Conjunctivitis
Primary: Ocular Itching Change From Baseline to Day 11 — -1.1; -0.45 units on a scale
Obesity
Primary: Change in Plasma Fractalkine Levels — 0.42; 0.46; 0.48; 0.45 ng/ml
Labor Pain
Primary: Volume of Local Anesthetic Received Through Patient Controlled Epidural Analgesia (PCEA) Per Hour — 4.03; 4.52 milliliters per hour — p=0.17
Osteoarthritis
Primary: Time to Meet Physical Therapy Discharge Criteria — 2109.3; 1883.1 Minutes
HIV
Primary: Platelet Reactivity Measured by Expression of P-selectin (CD62p) and Fibrinogen Binding — 0.9; 0.96; 1; 0.99 Ratio
Breast Cancer
Primary: Injection Site Clearance for Lymphoseek and 99mTc-Sulfur Colloid (SC). — 1.78; 0.045 minutes
Smoking Cessation
Primary: Smoking Abstinence — 21; 8 Participants
Obesity · Mycoses
Primary: Serum Clearance of Anidulafungin — 0.94 L/hr
Psoriasis
Primary: Change in Psoriasis Area and Severity Index (PASI) Score — 13.92; 4.43 units on a scale — p=0.38
Alcohol Dependence · Bipolar Disorder · Depression
Primary: Percent Days Abstinent From Alcohol — 78.7; 80.1 Percentage of days abstinent